Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021

SELL
$6.78 - $9.89 $103,679 - $151,237
-15,292 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$7.24 - $11.2 $7,240 - $11,200
1,000 Added 7.0%
15,292 $123,000
Q1 2021

May 04, 2021

SELL
$8.05 - $20.78 $281 - $727
-35 Reduced 0.24%
14,292 $154,000
Q4 2020

Feb 11, 2021

BUY
$2.36 - $9.99 $33,811 - $143,126
14,327 New
14,327 $123,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.